Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives.

Seefried L, Duplan MB, Briot K, Collins MT, Evans R, Florenzano P, Hawkins N, Javaid MK, Lachmann R, Ward LM

Front Endocrinol (Lausanne)